Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Orphazyme A/S ADR
(NQ:
ORPH
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 30, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Orphazyme A/S ADR
< Previous
1
2
3
4
5
6
7
Next >
Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs
March 22, 2022
Orphazyme A/S (NASDAQ: ORPH) has
Via
Benzinga
Dear ORPH Stock Fans, Mark Your Calendars for March 31
March 22, 2022
After Orphazyme announced that it would withdraw the application for approval of its drug and delist its ADSs, ORPH stock is falling.
Via
InvestorPlace
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 22, 2022
Grab your cup of coffee, investor! We're starting off the day with a dive into the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Why Is Orphazyme (ORPH) Stock Up Today?
March 17, 2022
The troubled biotech company's share price is up 40% despite plans to delist from the Nasdaq exchange and lay off 50% of its workers.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Friday
March 11, 2022
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest...
Via
Benzinga
30 Stocks Moving in Tuesday's Pre-Market Session
March 22, 2022
Gainers Smart for Life, Inc. (NASDAQ: SMFL) rose 75.3% to $1.63 in pre-market trading. Smart For Life recently said it is launching various products under the Doctors Scientific...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 21, 2022
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.
Via
Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
March 17, 2022
Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results. Allego N.V. (NASDAQ: ALLG) shares gained 45.5% to $9.40. Spartan...
Via
Benzinga
64 Biggest Movers From Yesterday
March 18, 2022
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...
Via
Benzinga
Why Is OXY Stock Up Today? Does Warren Buffett’s Berkshire Want to Buy Occidental Petroleum?
March 17, 2022
Occidental Petroleum (OXY) stock is rising higher on Thursday following news that Berkshire Hathaway increased its stake in the company.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 17, 2022
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 31.0% to $1.31 during Thursday's pre-market session. The company's market cap stands at $36.7 million....
Via
Benzinga
22 Stocks Moving in Thursday's Pre-Market Session
March 17, 2022
Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 81.2% to $0.43 in pre-market trading after the company reported FY21 results. Orphazyme A/S (NASDAQ: ORPH) shares rose 35.1% to $0....
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Orphazyme Shares Plunge
March 11, 2022
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq dropping 150 points on Friday. The Dow traded up 0.07% to 33,198.82 while the NASDAQ fell 1.18% to 12,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 11, 2022
Gainers Clearside Biomedical (NASDAQ:CLSD) shares increased by 35.2% to $1.82 during Friday's regular session. Clearside Biomedical's stock is trading at a volume...
Via
Benzinga
95 Biggest Movers From Friday
March 14, 2022
Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9....
Via
Benzinga
Mid-Day Market Update: Gold Down 1%; Clearside Biomedical Shares Jump
March 11, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq dropping around 100 points on Friday. The Dow traded up 0.49% to 33,336.14 while the NASDAQ fell 0.73% to 13,032....
Via
Benzinga
50 Stocks Moving In Friday's Mid-Day Session
March 11, 2022
Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares rose 63.5% to $1.13....
Via
Benzinga
Orphazyme Calls For Court-Mediated Restructuring, Lays Off 50% Workforce
March 11, 2022
Orphazyme A/S's (NASDAQ: ORPH) board of directors has called for a court-mediated restructuring, prompting the second round of layoffs in less than a year. The in-...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 11, 2022
Good morning, traders! We're starting the final day of the workweek with a look at the biggest pre-market stock movers for Friday!
Via
InvestorPlace
30 Stocks Moving in Friday's Pre-Market Session
March 11, 2022
Gainers Excellon Resources Inc. (NYSE: EXN) rose 133.7% to $2.29 in pre-market trading after jumping around 13% on Thursday. Marygold Companies (NYSE: MGLD) rose 107.4% to...
Via
Benzinga
Benzinga's After-Hours Movers & News: DocuSign, Clearside Biomedical And More
March 10, 2022
Benzinga's “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro's...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 10, 2022
Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 14.8% to $1.55 during Thursday's after-market session. The company's market cap stands at $92.4 million. As per the press release, Q4...
Via
Benzinga
88 Biggest Movers From Yesterday
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Surges 2%; South Jersey Industries Shares Spike Higher
February 24, 2022
U.S. stocks pared some earlier losses toward the end trading, with the Nasdaq jumping 2% on Thursday. US President Biden, during his press briefing on Ukraine/Russia, said he...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 24, 2022
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...
Via
Benzinga
Mid-Day Market Update: Dow Drops Over 500 Points; Crude Oil Surges 6%
February 24, 2022
U.S. stocks remained lower midway through trading on Thursday after Russia’s President Vladimir Putin announced that the country’s armed forces would carry out a...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
February 24, 2022
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0....
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
EMA's Advisory Committee Does Not Back Orphazyme's Arimoclomol Application
February 24, 2022
Orphazyme A/S (NASDAQ: ORPH) has been notified by the Committee for Medicinal Products for Human Use (CHMP) of a negative trend vote on arimoclomol application ...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.